Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Ginkgo and Improved Alzheimer Disease Assessment Scale-Noncognitive Subscale Score

Doses used in studies

With Piperine · mg/day: 100 (median 100, IQR 100–100) — 1 study

Time to effect

Median: 5.6 months · IQR 5.6 months–5.6 months · Range 5.6 months–5.6 months — Reported in 1 of 1 study

1 of 1 paper

Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- 2024-06-14
- RCT · n = 119
- Medicine 103(24)
- - Wankiun Lee
  - Manho Kim
- PubMed: 38875437
- DOI: 10.1097/md.0000000000038067
3 Insights on
- Improved Alzheimer Disease Assessment Scale-Noncognitive Subscale Score
- High evidence
- Large Human Trial
- Clinical
No separate positive result for DG; DN group showed better performance.
Effect
Neutral
Effect size
Small
Significant
No
Dose
not stated